CVS Health Corporation (NYSE:CVS) has been given a $86.00 target price by equities research analysts at Jefferies Group LLC in a research report issued on Wednesday. The firm presently has a “hold” rating on the pharmacy operator’s stock. Jefferies Group LLC’s price objective indicates a potential upside of 12.43% from the stock’s previous close.

Several other brokerages have also recently issued reports on CVS. Royal Bank Of Canada began coverage on shares of CVS Health Corporation in a report on Tuesday, September 19th. They issued an “outperform” rating and a $95.00 target price for the company. Needham & Company LLC began coverage on shares of CVS Health Corporation in a report on Tuesday, June 27th. They issued a “hold” rating for the company. Guggenheim restated a “buy” rating on shares of CVS Health Corporation in a report on Monday, July 3rd. Leerink Swann set a $90.00 target price on shares of CVS Health Corporation and gave the company a “buy” rating in a report on Tuesday, June 27th. Finally, BidaskClub upgraded shares of CVS Health Corporation from a “sell” rating to a “hold” rating in a report on Wednesday, August 2nd. One research analyst has rated the stock with a sell rating, eight have assigned a hold rating and sixteen have assigned a buy rating to the company’s stock. The company has a consensus rating of “Buy” and a consensus target price of $89.68.

CVS Health Corporation (NYSE:CVS) traded up 2.49% during midday trading on Wednesday, reaching $76.49. 9,144,918 shares of the company were exchanged. The firm has a 50-day moving average price of $78.86 and a 200-day moving average price of $78.71. CVS Health Corporation has a 52 week low of $69.30 and a 52 week high of $88.58. The company has a market capitalization of $77.76 billion, a PE ratio of 15.30 and a beta of 0.92.

CVS Health Corporation (NYSE:CVS) last posted its quarterly earnings results on Tuesday, August 8th. The pharmacy operator reported $1.33 EPS for the quarter, topping the consensus estimate of $1.31 by $0.02. CVS Health Corporation had a net margin of 2.93% and a return on equity of 17.47%. The company had revenue of $45.69 billion during the quarter, compared to analysts’ expectations of $45.36 billion. During the same quarter in the previous year, the business posted $1.32 EPS. The firm’s revenue was up 4.5% on a year-over-year basis. Equities research analysts anticipate that CVS Health Corporation will post $5.88 earnings per share for the current fiscal year.

COPYRIGHT VIOLATION WARNING: This news story was originally published by American Banking News and is owned by of American Banking News. If you are viewing this news story on another website, it was illegally stolen and republished in violation of United States & international trademark and copyright law. The legal version of this news story can be viewed at https://www.americanbankingnews.com/2017/10/22/jefferies-group-llc-reiterates-86-00-price-target-for-cvs-health-corporation-cvs.html.

In other CVS Health Corporation news, COO Jonathan C. Roberts sold 85,743 shares of the company’s stock in a transaction on Monday, September 18th. The shares were sold at an average price of $83.14, for a total transaction of $7,128,673.02. Following the completion of the transaction, the chief operating officer now owns 119,555 shares in the company, valued at approximately $9,939,802.70. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, CFO David M. Denton sold 237,078 shares of the company’s stock in a transaction on Monday, September 11th. The stock was sold at an average price of $79.65, for a total transaction of $18,883,262.70. Following the transaction, the chief financial officer now owns 141,096 shares of the company’s stock, valued at approximately $11,238,296.40. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 716,625 shares of company stock valued at $58,318,431. 0.61% of the stock is owned by insiders.

Institutional investors have recently made changes to their positions in the business. Northwestern Mutual Wealth Management Co. raised its position in CVS Health Corporation by 3.2% during the 1st quarter. Northwestern Mutual Wealth Management Co. now owns 176,294 shares of the pharmacy operator’s stock worth $13,840,000 after buying an additional 5,478 shares during the last quarter. Fiduciary Trust Co. raised its position in CVS Health Corporation by 1.2% during the 1st quarter. Fiduciary Trust Co. now owns 366,007 shares of the pharmacy operator’s stock worth $28,732,000 after buying an additional 4,265 shares during the last quarter. British Columbia Investment Management Corp raised its position in CVS Health Corporation by 3.7% during the 1st quarter. British Columbia Investment Management Corp now owns 561,299 shares of the pharmacy operator’s stock worth $44,062,000 after buying an additional 19,794 shares during the last quarter. Independent Advisor Alliance raised its position in CVS Health Corporation by 6.7% during the 1st quarter. Independent Advisor Alliance now owns 26,460 shares of the pharmacy operator’s stock worth $2,038,000 after buying an additional 1,652 shares during the last quarter. Finally, Bahl & Gaynor Inc. raised its position in CVS Health Corporation by 1.1% during the 1st quarter. Bahl & Gaynor Inc. now owns 14,922 shares of the pharmacy operator’s stock worth $1,171,000 after buying an additional 167 shares during the last quarter. Institutional investors own 81.46% of the company’s stock.

About CVS Health Corporation

CVS Health Corporation, together with its subsidiaries, is an integrated pharmacy healthcare company. The Company provides pharmacy care for the senior community through Omnicare, Inc (Omnicare) and Omnicare’s long-term care (LTC) operations, which include distribution of pharmaceuticals, related pharmacy consulting and other ancillary services to chronic care facilities and other care settings.

Analyst Recommendations for CVS Health Corporation (NYSE:CVS)

Receive News & Ratings for CVS Health Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health Corporation and related companies with MarketBeat.com's FREE daily email newsletter.